[Federal Register Volume 67, Number 112 (Tuesday, June 11, 2002)]
[Notices]
[Pages 39995-39996]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-14563]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30DAY-33-02]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 498-1210. Send written 
comments to CDC, Desk Officer, Human Resources and Housing Branch, New 
Executive Office Building, Room 10235, Washington, DC 20503. Written 
comments should be received within 30 days of this notice.
    Proposed Project: Surveillance for Bloodstream and Vascular Access 
Infections in Outpatient Hemodialysis Centers (0920-0442)--Revision--
National Center for Infectious Diseases (NCID), NCID Centers for 
Disease Control and Prevention (CDC), is proposing to renew a study of 
bloodstream infections, vascular access infections, hospitalization, 
and antimicrobial starts at U.S. outpatient hemodialysis centers. 
Although bloodstream and vascular access infections are common in 
hemodialysis patients, there was previously no system to record and 
track these complications.
    Participation in the proposed project is voluntary. Currently about 
80-90 centers report data each month. We estimate that about 100 of the 
approximately 4,500 U.S. outpatient hemodialysis centers will 
participate in the coming years. Participating centers may collect data 
continuously, or may discontinue participation at any time; we estimate 
that the average center will participate for nine months. Each month, 
participating centers will record the number of hemodialysis patients 
they treat and maintain a log of all hospitalizations and intravenous 
(IV) antimicrobial starts. For each hospitalization or IV antimicrobial 
start, further information (e.g., type of vascular access, clinical 
symptoms, presence of a vascular access infection, and blood culture 
results) will be collected. These data may be reported to CDC on paper 
forms or via a secure Internet site. CDC aggregates this data and 
generates reports which are sent to participating dialysis centers.
    Centers that participate in the Internet-based reporting system may 
also analyze their own data and print out reports as desired. Rates of 
bloodstream infection, vascular access infection, and antimicrobial use 
per 1000 patient-days will be calculated.
    Also, the percentage of antimicrobial starts for which a blood 
culture is performed will be calculated. Through use of these data, 
dialysis centers will be able to track rates of key infectious 
complications of hemodialysis. This will facilitate quality control 
improvements to reduce the incidence of infections, and clinical 
practice guidelines to improve use of antimicrobials. The total 
estimated annualized burden is 6,300 hours.

----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden/
                              Form                                   Number of      responses/     response (in
                                                                    respondents     respondent        hours)
----------------------------------------------------------------------------------------------------------------
Agreement to participate........................................             100               1               1
Census form.....................................................             100              12               1
Log.............................................................             100              12               1
Incident form...................................................             100             200           12/60
----------------------------------------------------------------------------------------------------------------



[[Page 39996]]

    Dated: May 31, 2002.
Julie Fishman,
Acting Associate Director for Policy, Planning and Evaluation, Centers 
for Disease Control and Prevention.
[FR Doc. 02-14563 Filed 6-10-02; 8:45 am]
BILLING CODE 4163-18-P